EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 183 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $334,000 | -60.3% | 4,813 | -69.5% | 0.00% | – |
| Q4 2017 | $842,000 | -59.9% | 15,767 | -55.3% | 0.00% | – |
| Q3 2017 | $2,102,000 | -24.4% | 35,245 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $2,780,000 | +584.7% | 35,245 | +619.7% | 0.00% | – |
| Q1 2017 | $406,000 | -46.4% | 4,897 | -73.8% | 0.00% | – |
| Q1 2016 | $757,000 | -72.1% | 18,700 | -38.9% | 0.00% | -100.0% |
| Q4 2015 | $2,715,000 | +39.7% | 30,617 | +16.6% | 0.00% | 0.0% |
| Q3 2015 | $1,943,000 | +352.9% | 26,250 | +395.3% | 0.00% | – |
| Q2 2015 | $429,000 | – | 5,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |